Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,755,200
+$104,489 QoQ
Shares Held
14,786
-1.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.66%
of 13F equity value
Holder Rank
#1,828
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VeraBank, N.A. holds $15,922,408 across 9 Drug Manufacturers - General names. JNJ ranks #1 (23.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
14,786 | $3,755,200 | |
| 2 | ABBV |
AbbVie Inc.
|
14,486 | $3,645,256 | |
| 3 | LLY |
ELI LILLY & Co
|
2,632 | $3,156,900 | |
| 4 | AMGN |
Amgen Inc
|
4,636 | $1,678,788 | |
| 5 | MRK |
Merck & Co., Inc.
|
10,222 | $1,313,526 | |
| 6 | GSK |
GSK plc
|
20,501 | $1,074,662 | |
| 7 | PFE |
Pfizer Inc
|
28,634 | $689,506 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,797 | $353,372 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,755,200 | 14,786 | Shares | Other | 2026-08-06 | |
| 2026-03-31 | $3,650,711 | 14,935 | Shares | Other | 2026-05-12 | |
| 2025-12-31 | $3,152,675 | 15,234 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $2,824,687 | 15,234 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $2,371,290 | 15,524 | Shares | Other | 2025-08-08 | |
| 2025-03-31 | $2,291,245 | 13,816 | Shares | Other | 2025-05-09 | |
| 2024-12-31 | $2,010,940 | 13,905 | Shares | Other | 2025-01-30 | |
| 2024-09-30 | $1,977,131 | 12,200 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,824,953 | 12,486 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $1,981,170 | 12,524 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,963,951 | 12,530 | Shares | Other | 2024-02-06 | |
| 2023-09-30 | $1,966,187 | 12,624 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $2,099,455 | 12,684 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $1,979,040 | 12,768 | Shares | Other | 2023-04-20 | |
| 2022-12-31 | $2,349,444 | 13,300 | Shares | Other | 2023-01-25 | |
| 2022-09-30 | $2,183,796 | 13,368 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $2,420,170 | 13,634 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $2,486,890 | 14,032 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $2,482,053 | 14,509 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $2,419,754 | 14,983 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $2,377,691 | 14,433 | Shares | Other | 2021-08-04 | |
| 2021-03-31 | $2,472,809 | 15,046 | Shares | Sole | 2021-04-13 | |
| 2020-12-31 | $2,367,938 | 15,046 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $2,345,157 | 15,752 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $2,242,625 | 15,947 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $2,107,389 | 16,071 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||